» Authors » Eliza Kwiatkowska-Borowczyk

Eliza Kwiatkowska-Borowczyk

Explore the profile of Eliza Kwiatkowska-Borowczyk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 147
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gabka-Buszek A, Kwiatkowska-Borowczyk E, Jankowski J, Kozlowska A, Mackiewicz A
Vaccines (Basel) . 2020 Apr; 8(2). PMID: 32224883
Therapeutic cancer vaccines have elicited renewed interest due to the development of immune checkpoint inhibitors. The role of these vaccines is to induce specific effector cells for killing cancer cells....
2.
Kwiatkowska-Borowczyk E, Czerwinska P, Mackiewicz J, Gryska K, Kazimierczak U, Tomela K, et al.
Oncoimmunology . 2018 Nov; 7(11):e1509821. PMID: 30377573
Allogeneic whole cell gene modified therapeutic melanoma vaccine (AGI-101H) comprising of two melanoma cell lines transduced with cDNA encoding fusion protein composed of IL-6 linked with the soluble IL-6 receptor...
3.
Hojan K, Kwiatkowska-Borowczyk E, Leporowska E, Milecki P
Pol Arch Intern Med . 2017 Jan; 127(1):25-35. PMID: 28075422
INTRODUCTION Previous studies have shown that physical exercise in cancer patients during radiation therapy (RT) and androgen deprivation therapy (ADT) improves cardiac fitness and quality of life (QoL), as well...
4.
Dams-Kozlowska H, Kwiatkowska-Borowczyk E, Gryska K, Lewandowska A, Marszalek A, Adamczyk S, et al.
PLoS One . 2016 May; 11(5):e0154520. PMID: 27144685
The incidence of cancer is constantly increasing. Chemo/radiotherapy is one of major methods of treating cancer. Although adverse chemo/radiotherapy events, such as anemia and neutropenia, can be successfully cured, thrombocytopenia...
5.
Hojan K, Kwiatkowska-Borowczyk E, Leporowska E, Gorecki M, Ozga-Majchrzak O, Milecki T, et al.
Eur J Phys Rehabil Med . 2016 Jan; 52(4):489-501. PMID: 26761561
Background: During radiotherapy (RT), prostate cancer (PCa) patients may report cancer related fatigue (CRF), which impairs functional capacity, psychological status, and quality of life (QoL). RT can induce cytokine responses...
6.
Piotrowska H, Myszkowski K, Abraszek J, Kwiatkowska-Borowczyk E, Amarowicz R, Murias M, et al.
Biomed Pharmacother . 2014 Apr; 68(4):397-400. PMID: 24768110
DMU-212 has been shown to evoke a mitochondrial apoptotic pathway in transformed fibroblasts and breast cancer. However, recently published data indicated the ability of DMU-212 to evoke apoptosis in both...
7.
Dams-Kozlowska H, Kwiatkowska-Borowczyk E, Gryska K, Mackiewicz A
Int J Med Sci . 2013 Jul; 10(9):1157-65. PMID: 23869192
Interleukin-11 (IL-11) displays megakaryopoietic activity. We constructed super-cytokine Hyper- IL11 (H11) by linking soluble IL-11 receptor α (sIL-11Rα) with IL-11, which directly targets β-receptor (gp130) signal transducing subunit. The effects...
8.
Piotrowska H, Myszkowski K, Ziolkowska A, Kulcenty K, Wierzchowski M, Kaczmarek M, et al.
Toxicol Appl Pharmacol . 2012 Jun; 263(1):53-60. PMID: 22687606
In the screening studies, cytotoxicity of 12 methylated resveratrol analogues on 11 human cancer cell lines was examined. The most active compound 3,4,4'5-tetramethoxystilbene (DMU-212) and two ovarian cancer cell lines...
9.
Dams-Kozlowska H, Gryska K, Kwiatkowska-Borowczyk E, Izycki D, Rose-John S, Mackiewicz A
BMC Biotechnol . 2012 Mar; 12:8. PMID: 22433466
Background: Interleukin 11 (IL-11) is a pleiotropic cytokine with anti-apoptotic, anti-inflammatory and hematopoietic potential. The IL-11 activity is determined by the expression of the IL-11R receptor alpha (IL-11Rα) and the...